Metsera, a biotechnology company focused on obesity treatments, has successfully raised $215 million in a Series B funding round, following an earlier $290 million raised just seven months prior. The funding round was co-led by Venrock, which expressed enthusiasm for the company's future achievements. Additionally, Medeloop has completed its Series A funding to enhance its AI-driven approach to medical research, with notable contributions from investors including Inovia. MetaSight Diagnostics also announced the closure of an $8 million oversubscribed Series A round, while PulseNoLimits secured $1.8 million in a pre-seed round, co-led by Lemniscap and Collab Currency. These funding activities reflect a growing interest in innovative healthcare solutions and technologies.